Description

4-(1-Ethyl-1H-Benzoimidazol-2-Yl)-Butyric Acid CAS NO 878436-85-2 is a high-purity, functionalized benzoimidazole derivative that serves as a critical building block in advanced organic synthesis. This compound is valued for its unique molecular structure, which combines a benzoimidazole core with a flexible carboxylic acid-terminated alkyl chain, enabling its use in the development of novel active pharmaceutical ingredients (APIs) and specialty materials. It is primarily sought by research institutions and industrial manufacturers in the pharmaceutical, agrochemical, and material science sectors for the synthesis of complex molecules with targeted biological or physical properties.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting enzyme inhibition or receptor modulation.
• Agrochemical Research: Used in the development of new herbicides, fungicides, and plant growth regulators that leverage the benzoimidazole pharmacophore.
• Ligand Synthesis: Serves as a versatile starting material for creating complex ligands used in catalysis and metal-organic frameworks (MOFs).
• Polymer Modification: The carboxylic acid group allows for incorporation into polymer chains to impart specific functional properties.
• Chemical Biology Probes: Utilized in the design and synthesis of molecular probes for studying biological processes and pathways.
• Material Science: Investigated for the development of organic electronic materials and advanced coatings.

Basic Information

Product Name	4-(1-Ethyl-1H-Benzoimidazol-2-Yl)-Butyric Acid
CAS No.	878436-85-2
Molecular Formula	C₁₃H₁₆N₂O₂
Molecular Weight	232.28 g/mol
Synonyms	4-(1-Ethyl-1H-benzimidazol-2-yl)butanoic acid; 4-(1-Ethyl-1H-benzo[d]imidazol-2-yl)butyric acid; 2-(3-Carboxypropyl)-1-ethyl-1H-benzimidazole; 1-Ethyl-2-(3-carboxypropyl)benzimidazole; 4-(1-Ethylbenzimidazol-2-yl)butyric acid; Butanoic acid, 4-(1-ethyl-1H-benzimidazol-2-yl)-; 878436-85-2
EINECS	Contact for details

Quality Control

Our production of 4-(1-Ethyl-1H-Benzoimidazol-2-Yl)-Butyric Acid adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including HPLC for purity assessment and NMR/IR for structural confirmation. Certificates of Analysis (COA) detailing all specifications are provided with every shipment. We support cGMP-compliant manufacturing for pharmaceutical applications and can tailor quality specifications to meet specific client requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The product is light-sensitive (store away from light) and should be kept under inert conditions if long-term storage is required. Keep away from strong acids and organic solvents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.